Q1 2026 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2026-05-15 · accession 0000919574-26-003144
$1.42B
Reported value
6
Positions
2026-03-31
Period end
The Brief · BROADWOOD CAPITAL INC · Q1 2026
AI · grounded in 13F
Broadwood Capital Inc exited its position in UAL, reducing its holdings by $16.77M. The fund also closed positions in AAL and LUV, resulting in decreases of $12.57M and $7.56M respectively. Conversely, the fund increased its share counts in STAA by 7.35% and IMDX by 4.57%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $587.5M | 41.4% | 8,107,796 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $301.5M | 21.3% | 16,123,842 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $294.5M | 20.8% | 693,504 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $117.8M | 8.30% | 474,920 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS INC | $78.3M | 5.52% | 49,560,992 | Common | SOLE |
| 68235C206 | IMDX | INSIGHT MOLECULAR DIA INC | $39.1M | 2.76% | 11,931,839 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.